Abstract

Exosomes are 30-150nM membrane-bound secreted vesicles that are readily isolated from biological fluids such as urine (UEs). Exosomes contain proteins, micro RNA (miRNA), messenger RNA (mRNA), and long non-coding RNA (lncRNA) from their cells of origin. Although miRNA, protein and lncRNA have been isolated from serum as potential biomarkers for benign and malignant disease, it is unknown if lncRNAs in UEs from urothelial bladder cancer (UBC) patients can serve as biomarkers. lncRNAs are > 200 nucleotide long transcripts that do not encode protein and play critical roles in tumor biology. As the number of recognized tumor-associated lncRNAs continues to increase, there is a parallel need to include lncRNAs into biomarker discovery and therapeutic target algorithms. The lncRNA HOX transcript antisense RNA (HOTAIR) has been shown to facilitate tumor initiation and progression and is associated with poor prognosis in several cancers. The importance of HOTAIR in cancer biology has sparked interest in using HOTAIR as a biomarker and potential therapeutic target. Here we show HOTAIR and several tumor-associated lncRNAs are enriched in UEs from UBC patients with high-grade muscle-invasive disease (HGMI pT2-pT4). Knockdown of HOTAIR in UBC cell lines reduces in vitro migration and invasion. Importantly, loss of HOTAIR expression in UBC cell lines alters expression of epithelial-to-mesenchyme transition (EMT) genes including SNAI1, TWIST1, ZEB1, ZO1, MMP1 LAMB3, and LAMC2. Finally, we used RNA-sequencing to identify four additional lncRNAs enriched in UBC patient UEs. These data, suggest that UE-derived lncRNA may potentially serve as biomarkers and therapeutic targets.

Highlights

  • LncRNAs, are transcripts that are 5’ 7-methylguanosine capped and either poly-adenylated or unadenylated and are >200 nucleotide long

  • We show that HOX transcript antisense RNA (HOTAIR), HOX-AS2, Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), and lincRoR are overexpressed in tumors and enriched in urinary exosomes (UEs) from urothelial bladder cancer (UBC) patients with HGMI disease

  • There is growing interest in the roles that long non-coding RNA (lncRNA) play in tumor initiation and progression. lncRNA have been implicated in tumor progression through their effects on epigenetic modifying complexes, cellular senescence, response to chemotherapeutics, regulation of epithelial-tomesenchyme transition (EMT), response to hypoxia and ability to serve as micro RNA (miRNA) sponges [5,44,67,68,69,70]

Read more

Summary

Introduction

LncRNAs, are transcripts that are 5’ 7-methylguanosine capped and either poly-adenylated or unadenylated and are >200 nucleotide long. LncRNA are proving to be important mediators of normal cellular processes including, developmental imprinting, dosage compensation, and cellular differentiation as well as functions within mature cells such as control of splicing and hormone regulation [1,2]. Dysregulation of lncRNA expression has been shown to be important in malignant processes such as tumor progression [3,4,5,6]. With the advent of transcriptome-wide RNA-sequencing (RNA-seq) the discovery of lncRNAs has increased significantly. Iyer et al applied ab initio assembly to RNAsequencing (RNA-seq) libraries from several tumors to reveal thousands of lineage and cancerassociated lncRNAs underscoring the importance of including lncRNA into biomarker and therapeutic target discovery algorithms [7]. Exosomes participate in intercellular communication by delivering proteins, miRNA, mRNA, and lncRNA to recipient cells [15,16]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call